Finance

Lists
300760:SHE
Shenzhen Mindray Bio-Medl Elctrnc Co Ltd
CNÂ¥185.38
+0.59%
(+1.08) 1D
Nov 17, 3:04:10 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300760...
Open
CNÂ¥184.00
High
CNÂ¥185.91
Low
CNÂ¥182.11
Mkt. cap
223.33B
Avg. vol.
10.15M
Volume
8.62M
Dividend
2.26%
Quarterly dividend
CNÂ¥1.05
Ex-dividend date
Sep 8, 2026
P/E ratio
28.99
52-wk high
CNÂ¥214.12
52-wk low
CNÂ¥130.66
EPS
CNÂ¥6.39
Shares outstanding
1.21B
No. of employees
21K
Open
CNÂ¥184.00
High
CNÂ¥185.91
Low
CNÂ¥182.11
Mkt. cap
223.33B
Avg. vol.
10.15M
Volume
8.62M
Dividend
2.26%
Quarterly dividend
CNÂ¥1.05
Ex-dividend date
Sep 8, 2026
P/E ratio
28.99
52-wk high
CNÂ¥214.12
52-wk low
CNÂ¥130.66
EPS
CNÂ¥6.39
Shares outstanding
1.21B
No. of employees
21K
News stories
From web sources and news partners
Profile
Mindray Bio-Medical Electronics Co., Ltd., simply known as Mindray, is a Chinese multinational health technology company based in Shenzhen, Guangdong. Mindray designs and produces medical equipment and accessories for both human and veterinary use. The company is organized into three key business lines: Patient Monitoring & Life Support, In-Vitro Diagnostic Products, and Medical Imaging Systems. In 2008, Mindray was recognized as China's largest medical device manufacturer. Wikipedia
About Shenzhen Mindray Bio-Medl Elctrnc Co Ltd
CEO-
Employees21.3K
Founded1991
Headquarters-
SectorHealth Care
IndustryMedical device
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
7.45B
8.35B
9.39B
9.35B
Cost of goods sold
3.70B
3.18B
3.83B
3.54B
Cost of revenue
3.70B
3.18B
3.83B
3.54B
Research and development expenses
1.14B
801.74M
767.77M
813.21M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.91B
1.58B
1.63B
1.70B
Operating expense
3.19B
2.39B
2.44B
2.48B
Total operating expenses
6.89B
5.57B
6.27B
6.03B
Operating income
563.02M
2.78B
3.12B
3.32B
Other non operating income
13.79M
-332.20M
288.46M
-1.00B
EBT including unusual items
772.35M
2.54B
3.01B
2.88B
EBT excluding unusual items
581.57M
2.57B
2.97B
3.04B
Income tax expense
134.78M
114.81M
394.38M
361.25M
Effective tax rate
17.45%
4.52%
13.08%
12.55%
Other operating expenses
90.41M
-9.50M
47.65M
-40.67M
Net income
565.73M
2.33B
2.47B
2.39B
Net profit margin
7.60%
27.89%
26.26%
25.53%
Earnings per share
-
-
-
-
Interest and investment income
125.46M
124.39M
141.61M
150.30M
Interest expense
-7.27M
-6.07M
-5.92M
-5.19M
Net interest expenses
118.19M
118.32M
135.69M
145.11M
Depreciation and amortization charges
-
-
-
-
EBITDA
951.35M
3.17B
3.55B
3.71B
Gain or loss from assets sale
-10.72M
-
9.02M
-9.02M
Upcoming events
AI content may include mistakes. Learn more
Google apps